
THOUSAND OAKS, Calif., Feb. 4, 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced financial results for the fourth quarter and full year of 2024 versus comparable periods in 2023. “Robust growth in sales and earnings throughout 2024 reflects the momentum of our business. With strong…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
